Comparison of the Analgesic Efficacy of Adductor Canal Block Versus Adductor Canal Plus Biceps Femoris Short Head Block in Patients Undergoing Knee Arthroscopy
bifes knee
1 other identifier
interventional
50
1 country
1
Brief Summary
This prospective, randomized, controlled, and multicenter clinical study aims to compare the postoperative analgesic efficacy of two regional anesthesia techniques commonly used in knee arthroscopy: adductor canal block (ACB) and combined adductor canal block plus biceps femoris short head (ACB+BiFeS) block. The study will evaluate postoperative pain control, opioid consumption, adverse effects, hospital stay, and patient satisfaction. Findings will help determine the most effective and safe method for postoperative analgesia in knee arthroscopy patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2025
CompletedStudy Start
First participant enrolled
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
November 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedJanuary 20, 2026
November 1, 2025
4 months
November 17, 2025
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Opioid Consumption (Tramadol, mg)
The total dose of tramadol administered via intravenous patient-controlled analgesia (PCA) device within the first 24 hours postoperatively will be recorded in milligrams.
24 hours
Secondary Outcomes (6)
Postoperative Pain with Movement and at rest (NRS)
At 0, 6, 12, and 24 hours after surgery
Rescue Analgesia Requirement
Within the first 24 hours postoperatively
Incidence of Nausea and Vomiting
Within the first 24 hours postoperatively
Quality of Recovery (QOR-15 score)
At 24 hours after surgery
Dermatomal Spread of Block
2nd hour postoperatively
- +1 more secondary outcomes
Study Arms (2)
Adductor Canal Block (ACB)
ACTIVE COMPARATORParticipants will undergo ultrasound-guided adductor canal block at the end of surgery under spinal anesthesia.
Adductor Canal Block + Biceps Femoris Short Head Block (ACB+BiFeS)
ACTIVE COMPARATORParticipants will undergo both adductor canal block and biceps femoris short head block at the end of surgery under spinal anesthesia.
Interventions
Ultrasound-guided injection of 10 mL 0.25% bupivacaine into the adductor canal targeting the femoral artery region, providing motor-sparing analgesia to the medial/anterior knee.
Combination of adductor canal block (10 mL 0.25% bupivacaine) and biceps femoris short head block with 25 mL 0.25% bupivacaine, deposited at the interfascial plane between BiFeS muscle and lateral femoral cortex to extend analgesia to the posterolateral knee.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- ASA physical status I-III
- Scheduled for elective knee arthroscopy under spinal anesthesia
- Ability to provide written informed consent
You may not qualify if:
- Coagulopathy or bleeding diathesis
- Current use of anticoagulant therapy
- Known allergy or contraindication to local anesthetics used in the study
- History of diabetes mellitus with neuropathy or other neuropathic disorders
- Contraindications to regional anesthesia techniques
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital
Istanbul, küçükçekmece, 34303, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Engin ihsan Turan, Specialist
Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will be blinded to group allocation. Outcome assessors recording pain scores, opioid consumption, and side effects will be blinded to the intervention. The anesthesiologists performing the blocks cannot be blinded due to the nature of the procedures.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
November 17, 2025
First Posted
November 21, 2025
Study Start
November 20, 2025
Primary Completion
March 10, 2026
Study Completion
March 30, 2026
Last Updated
January 20, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share